Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ·Healthcare·Biotechnology
$15.81
-0.72%
Mkt Cap $1.35B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $775.00K | — | — | -$0.14 | -$0.15 | -7.14% | — | — |
| Q4 2025 Nov 4, 2025 | — | — | — | -$0.14 | -$0.12 | +14.29% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.13 | -$0.10 | +23.08% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.13 | -$0.13 | +0.00% | — | — |
| Q1 2025 Mar 25, 2025 | — | — | — | -$0.12 | -$0.18 | -50.00% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.11 | -$0.11 | +0.00% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.12 | -$0.07 | +41.67% | — | — |
| Q2 2024 May 6, 2024 | — | — | — | -$0.12 | -$0.12 | +0.00% | — | — |
| Q1 2024 Mar 19, 2024 | — | $246.00K | — | -$0.14 | -$0.14 | +0.00% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.16 | -$0.12 | +25.00% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.14 | -$0.14 | +0.00% | — | — |
| Q2 2023 May 8, 2023 | — | — | — | -$0.16 | -$0.17 | -6.25% | — | — |
| Q1 2023 Mar 28, 2023 | — | — | — | $0.23 | -$0.21 | -191.30% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.16 | -$0.32 | -100.00% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.19 | -$0.18 | +5.26% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$0.14 | -$0.18 | -28.57% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | -$0.20 | -$0.20 | +0.00% | — | — |
| Q4 2021 Nov 1, 2021 | — | — | — | -$0.30 | -$0.24 | +20.00% | — | — |
| Q3 2021 Aug 2, 2021 | — | — | — | -$0.32 | -$0.28 | +12.50% | — | — |
| Q2 2021 Apr 29, 2021 | — | — | — | -$0.33 | -$0.34 | -3.03% | — | — |